Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism — Stella

Home/Hyperinsulinism/

View on ClinicalTrials.gov

Recruiting

Back to Hyperinsulinism trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Washington University, St Louis, Missouri

Key details

Phase

Safety & dosing

Sponsor

Washington University School of Medicine

Collaborators

St. Louis Children's Hospital

Enrollment target

~100 participants

Started

September 2020

Primary completion

January 2030

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.